Nasacort AQ, which is generically prescribed as triamcinolone nasal, and is commonly used to treat the nasal symptoms of allergies. Nasacort is considered a steroid. This medication prevents the chemicals in the body that create inflammation from being produced.
Nasacort AQ is not appropriate for everyone. A thorough medical history should be assessed prior to prescribing this medication. Patients with a medical history that includes viral infections, fungal infections, or bacterial infections, or a compromised immune system should not take Nasacort AQ. Nasacort AQ depletes the body’s ability to fight infection.
The American Food and Drug Administration has rated Nasacort AQ as a pregnancy risk category C, which means is has yet to be determined whether or not this medication will cause harm or side effects to an unborn baby. It has yet to be determined whether this medication will pass through the mother’s breast milk and affect a nursing baby. The prescribing physician should avoid prescribing this medication to a pregnant or nursing woman.
Nasacort AQ has a risk of side effects, some of which are severe. A patient that is experiencing a serious side effect or an allergic reaction should seek immediate emergency medical care. An allergic reaction will present with symptoms that include facial swelling, including swelling of the lips, mouth, tongue, or throat, hives, and difficulty breathing. Other serious side effects which require emergency medical attention include symptoms such as severe nasal burning or a nose bleed that can not be controlled.
Other less serious side effects typically do not require emergency medical attention however they should be reported to the prescribing physician. Patients should be encouraged to report all side effects. Less serious side effects include symptoms such as stinging in the nose, burning sensations, sneezing after use, inflammation of the nose, inflammation of the throat, nose bleeds, glaucoma, increased eye pressure, tearing of the eyes, headaches, perforated septum, lightheadedness, nausea, upset stomach, fever, cough, irritation or inflammation of the ears, nasal stuffiness, runny nose, unpleasant taste, or loss of smell. Less serious side effects can often be reduced to a tolerable level by reducing the dose of the medication.
Nasacort AQ should be taken exactly as prescribed by the physician. If the patient misses a dose, the dose should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to avoid the potential for an overdose. If an overdose or ingestion is suspected, the patient should seek immediate emergency medical treatment. Though it is unlikely to overdose on Nasacort AQ, an overdose would present with symptoms such as severe burning in the nostrils, uncontrollable nosebleed, and severe headache. Ingestion should not occur if this medication is kept out of reach of young children. Ingestion may result in nausea, vomiting, and diarrhea.
There is a risk of negative drug interactions associated with Nasacort. Patients should be urged to inquire with the prescribing physician prior to taking any new medications, including over the counter medications and herbal remedies. Medications that are known to cause negative interactions with Nasacort AQ include inhaled steroids, oral steroids, and additional nasal sprays.
Nasacort AQ comes in a metered dosage container which contains 120 doses. The patient should be instructed to properly discard the container after 120 doses. The canister will not deliver the required amount of medication after 120 doses.
Nasacort aq has the following structural formula:
Molecular formula of nasacort aq is C21H27FO6
Chemical IUPAC Name is 9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12, 13,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
Molecular weight is 394.434 g/mol
Nasacort aq available : 55mcg/act aerosol (nasal spray)
©2007-2017 Medicalook.com All rights reserved